デフォルト表紙
市場調査レポート
商品コード
911961

ガスクロマトグラフィーの世界市場:成長、動向、および予測(2021年~2026年)

Gas Chromatography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 112 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
ガスクロマトグラフィーの世界市場:成長、動向、および予測(2021年~2026年)
出版日: 2021年05月13日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 112 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のガスクロマトグラフィー市場は、2019年から2024年の間に7.2%のCAGRで成長する見通しです。

当レポートは世界のガスクロマトグラフィー市場について調査しており、市場機会や動向、成長および阻害要因、製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
  • 阻害要因
  • ポーターのファイブフォース分析

第5章 市場セグメント

  • 製品別
  • エンドユーザー別
    • 製薬・バイオ産業
    • 学術研究機関
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Agilent Technologies, Inc.
    • Chromatotec
    • Danaher Corporation
    • Falcon Analytical Systems &Technology, LLC
    • Merck KgaA
    • PerkinElmer, Inc.
    • Restek Corporation
    • Scion Instruments
    • 株式会社島津製作所
    • Thermo Fisher Scientific, Inc.

第7章 市場機会および今後の動向

目次
Product Code: 66772

The Gas Chromatography market was expected to witness a CAGR of 5.6% during the forecast period.

The COVID-19 pandemic is likely to have a slightly positive effect on the market. A study conducted in December 2020 and was published in 'The Lancet'. The study looked into gas chromatography techniques that can rapidly distinguish COVID-19 from other respiratory conditions, which can include influenza during the first diagnosis. The study was conducted at two sites in Edinburgh and Dortmund. Results from both sites indicated that patients who had contracted COVID-19 can be rapidly distinguished from patients with other conditions by gas chromatography methods at first healthcare contact. Novel uses of Gas Chromatography in the fight against COVID-19 are expected to boost the market growth.

The factors that are driving the market growth include increasing food safety concerns, the growing importance of chromatography tests in the drug approval process, and rising adoption of GC-MS.

Gas chromatography (GC) is widely accepted in both scientific and legal arenas, as one of the most powerful analytical techniques for separation, quantification, and identification of drug analytes, especially at low levels of concentration. GC is mostly done to analyze compounds that can be vaporized without decomposition. Gas chromatography is used extensively to test the purity of substances and to separate a mixture into its basic components. It has a profound use in analytical chemistry, owing to its ability to offer excellent features, like accurate separation capabilities, reproducibility, and quicker separation.

It is used in different fields, such as pharmaceuticals, cosmetics, and environmental toxins. Moreover, it can be used to analyze samples, which are volatile like exhaled human breath, blood, saliva, and other secretions. Air samples can be analyzed by using GC. Most of the air quality control units use GC coupled flame ionization detector (FID) to determine the components of a given sample.

Gas chromatography/ mass spectroscopy (GC/MS) is another useful method for determining the components of a given mixture, using the retention times and the abundance of the samples. GC method is used in many pharmaceutical applications, such as identifying the amount of chemical in drugs. Moreover, cosmetic manufacturers prefer GC technique to effectively measure the chemicals used in their products. Moreover, the European Medical Agency (EMA) has similar guidelines for drug analytics. Identification to discriminate between compounds of closely related structures are mostly done through GC/MS or HPLC/MS systems. However, the European Medical Agency does not consider the interpretation by chromatography techniques as specific.

Additionally, the use of GC and liquid chromatography for drug testing, especially to determine the purity and efficacy of new drug analytes has been approved by the National Institute of Health Sciences (NIHS), Japan. Thus, increased use of gas chromatography in drug approvals and growing support from the government, in the form of funds, are boosting the market growth

Gas chromatography (GC) was introduced over 60 years ago, and has since become a cornerstone technique for analytical chemistry. Advances in the area of column technology, such as the commercialization of high temperature stationary phases and silica capillaries stable to 480°C, has recently been put in the place. New materials such as sol-gel poly(ethylene glycol), nanoparticles, ionic liquids, and co-polymers have been incorporated in several novel Gas Chromatography stationary phases. Stationary phases have also been discussed for a long time in relation to microfabricated GC, i.e. chip-based GC. Such advancements are expected to propel the market growth over the forecast period all across the globe.

Key Market Trends

Pharmaceutical & BioIndustries are Expected to Hold Significant Market Share in the Application Segment

The COVID-19 pandemic is expected to have a positive effect on this segment. Since the pharmaceutical and bioindustry sectors have received huge amount of attention recently, this is expected to positively aid in the development of the gas chromatography market. In July 2020, an article was released in the 'Chromatography Today' magazine which stated that the US Air Force and researchers from the University of Michigan had collaborated to make modifications to an existing gas analysis system so that it can work like a breathalyser that can analyze the breath and detect the chemical signature of Acute Respiratory Distress Syndrome (ARDS) in its very early stages, which is a precursor to most COVID-19 infections. Developments such as these are expected to positively aid market growth.

The high efficiencies of separation power, the extreme detection sensitivity while detecting small amounts of separated species, and the accuracy and precision of the data from quantitative analyses of extremely complex mixtures are the major reasons why GC is used in the pharmaceutical industry. GC analyses are also less hassle-free while automating from sample introduction to separation. GC-MS is exclusively used in bio-analysis of blood, urine for the presence of barbiturates, alcohols, narcotics, residual solvents, drugs, like anesthetics, antihistamine, anticonvulsant, anti-epileptic drug, sedative hypnotics, and food items. Toxins and venoms can also be identified by GC-MS. It is extensively used in clinical toxicology too.

Rise in government funding in pharmaceutical R&D, technological advancements in the area of analytical instruments, increasing life science R&D expenditure, progressing drug discovery, and an increase in the adoption of GC are the key factors driving the growth of gas chromatography market, in the pharmaceutical and biotechnology industry. As a result of the aforementioned main advantages, short analysis time needed and reliable results, GC is extensively used as quality control purposes in the pharmaceutical and biotechnology industry.

North America Dominates the Market and Expected to do Same in the Forecast Period

In the North American region, gas chromatography technology is used in many applications. Chromatography instrumentation has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, and food testing, among others. Pharmaceutical organizations utilize gas chromatography, in order to get large amounts of greatly immaculate materials, and to examine the cleansed mixes. Other factors propelling the growth of the North American gas chromatography market, include the increasing need for drug discovery, rising prevalence of chronic diseases, and augmented demand for personalized medicines. The increasing focus on the development of improved and novel drug assessment techniques which has been used to discover highly complex drugs is playing a vital role in the evolution of new chromatographic methods in the region. In May 2017, Shimadzu Scientific Instruments (SSI) released its new Nexis GC-2030 gas chromatograph, offering a modern approach to a classic chromatographic technique.

The increased adoption of chromatography technique, majorly in food and beverage and pharmaceutical industries, drives the demand for gas chromatography in the region. With the rising number of critical diseases and the increase in the geriatric population in the region, healthcare expenditure has increased significantly in the region. This has increased R&D investments into the pharmaceutical industry for drug discovery and production, which has further increased the demand for chromatography technique in the North American region.

Competitive Landscape

The Gas Chromatography market is highly competitive and consists of a number of players. Companies like Agilent Technologies, Inc., Chromatotec, Restek Corporation, Danaher Corporation, Merck KgaA, Falcon Analytical Systems &Technology, LLC, PerkinElmer, Inc., Scion instruments, Shimadzu Corporation, Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the Gas Chromatography market.

Many strategic initiatives have taken recently in the market by the major players. For example, in January 2021, Sartorius announced it had entered into an agreement to acquire the chromatography process equipment division of Novasep.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Importance of Chromatography Tests in the Drug Approval Process
    • 4.2.2 Rising Adoption of GC-MS
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Gas Chromatography Equipment
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product
    • 5.1.1 Systems
    • 5.1.2 Detectors
    • 5.1.3 Auto-Samplers
    • 5.1.4 Fraction Collectors
    • 5.1.5 Others
  • 5.2 End User
    • 5.2.1 Pharmaceutical & BioIndustries
    • 5.2.2 Academic Research Institutes
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies, Inc.
    • 6.1.2 Chromatotec
    • 6.1.3 Danaher Corporation
    • 6.1.4 Falcon Analytical Systems &Technology, LLC
    • 6.1.5 Merck KgaA
    • 6.1.6 PerkinElmer, Inc.
    • 6.1.7 Restek Corporation
    • 6.1.8 Scion Instruments
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Thermo Fisher Scientific, Inc.
    • 6.1.11 Air Liquide
    • 6.1.12 LDetek inc.
    • 6.1.13 Hobre Instruments BV
    • 6.1.14 Waters Corporation
    • 6.1.15 Sartorius

7 MARKET OPPORTUNITIES AND FUTURE TRENDS